This section mainly discusses the changes of Cx43 in the brain of patients with depression, associated with inflammation, the possible role of Cx43 in treatment-resistant depression, the possible changes of Cx43 during the application of antidepressant and anti-inflammatory drugs, and the related pathogenesis. This evidence concerns the gene GJA1 and major depressive disorder.